YAP, a transcriptional co-activator amplifier, is a pivotal effector of the Hippo pathway in mouse and human cancers; YAP1 and YAP2 are potent oncogenic drivers and independent prognostic risk factors for HCC [27], [38], [46], [47]. Here, YAP1 is linked to hepatocellular carcinoma.